Both gene manipulation and pharmacologic studies demonstrated that elevated Orai1 results in hyperactivity of intracellular Ca2+ oscillations and, thus, controls rampant cell proliferation in ESCC cells. The gene discussed is ORAI1; the disease is esophageal squamous cell carcinoma.